TB Therapy Market Predicted to Reach $700 Million, But WTO Deal Casts Doubt on New Drug Development
NEW YORK (Reuters Health) – In a bid to promote industry interest in tuberculosis (TB) drugs, non-profit group the Global
NEW YORK (Reuters Health) – In a bid to promote industry interest in tuberculosis (TB) drugs, non-profit group the Global
In other health news: Trying to entice major drug companies into plunging into the tuberculosis market, the new Global Alliance
A nonprofit health group will issue a report Thursday designed to enlist drug makers in the fight against tuberculosis, a
Les maladies infectieuses constituent aujourd’hui la principale cause de mortalité dans le monde avec 17 millions de victimes chaque année.
Drug makers and wealthy governments aren’t doing enough to develop new medicines to combat several serious diseases that are prevalent
Maria Freire, director of NIH’s Office of Technology Transfer, has been chosen as the new CEO of the Global Alliance
Dr. Maria C. Freire, Ph.D. has been named the new chief executive officer of the Global Alliance for TB Drug
The first Gordon Research Conference on tuberculosis drug development was held at Colby-Sawyer College in New London, New Hampshire on
Grandes laboratórios investem pouco em tuberculose, malária e outras doenças de pobres Há dez anos, o médico Valdir Amato, pesquisador
The American Lung Association (ALA)is supporting authorizing bills introduced in Congress last March – with counterparts expected in Senate by